COVID-19 Vaccine Packaging and Delivery Devices Market
With the threat of new strains of Covid-19, vaccine developers are constantly engaged in R&D for vaccine development: Opportunities ahead for Covid-19 Vaccine Packaging and Delivery Devices
COVID-19 Vaccine Packaging and Delivery Devices Market by Product Type & Region | Forecast 2023 to 2033
COVID-19 Vaccine Packaging and Delivery Devices Market Outlook (2023 to 2033)
A newly released COVID-19 Vaccine Packaging and Delivery Devices Market analysis report by Future Market Insights reveals that global sales of the Covid-19 Vaccine Packaging and Delivery Devices in 2022 were held at US$ 1.1 billion. With a CAGR of 7.1% from 2023 to 2033, the market is projected to reach a valuation of US$ 2.2 billion by 2033. Syringes is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 6.8% from 2023 to 2033.
|
Attribute |
Details |
|
Global Covid-19 Vaccine Packaging and Delivery Devices Market (2023) |
US$ 1.1 billion |
|
Global Covid-19 Vaccine Packaging and Delivery Devices Market (2033) |
US$ 2.2 billion |
|
Global Covid-19 Vaccine Packaging and Delivery Devices Market CAGR (2023 to 2033) |
7.1% |
|
The USA Covid-19 Vaccine Packaging and Delivery Devices Market CAGR (2023 to 2033) |
7.5% |
|
Key Companies Profiled |
|
Let us know your requirement to get
100% FREE customization
Revenue of COVID-19 Vaccine Packaging and Delivery Devices Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033
As per the COVID-19 Vaccine Packaging and Delivery Devices Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the COVID-19 Vaccine Packaging and Delivery Devices Market increased at around 5.9% CAGR.
COVID-19 Vaccine Packaging and Delivery systems demand escalated due to the high death rate from COVID-19 infection in comparison to other viral infections such as influenza. Thus, the global demand for COVID-19 vaccination presented a significant chance for growth in the market. The need to package and transportation of the vaccines in time considering their sterilized state has created opportunities for the global COVID-19 Vaccine Packaging and Delivery Devices Market.
Many pharmaceutical companies are engaged in research and development and are likely to fabricate new serums in the market when new strains emerge. As packaging and delivery are an important part of each product's manufacturing, the market has significant growth opportunities during the forecasted period.
The COVID-19 Vaccine Packaging and Delivery Devices Market is also likely to boost throughout the forecasted period owing to an increase in the demand for needle-free products to reduce pain and injuries associated with vaccination along with increased attempts to develop vaccine delivery systems.
The market is being largely driven by expanding immunization programs, expanding vaccination efforts and campaigns, and rising Covid occurrences globally. The increasing financial assistance from the government and non-governmental organizations has resulted in numerous innovations in the area, consequently increasing market size.
Additionally, with the increasing financing and efforts towards research and development, the market will further witness an upside move. These efforts are aimed at developing a new vaccine and developing packaging material and delivery devices.
The demand for COVID-19 Vaccine Packaging and Delivery Devices is huge, especially in countries like India and China, which have almost one-third of the world population. In addition, since these countries have been most active in the manufacturing of Covid-19 vaccines, there exist significant growth prospects for the market in these countries.
What Factors are Propelling COVID-19 Vaccine Packaging and Delivery Devices Demand?
The huge spike in the number of people affected by the Covid-19 virus created a huge demand for vaccines worldwide. The huge demand led to an increase in the manufacturing of these vaccines in order to curb its menace. The rising prevalence of communicable diseases and strong support from the government for vaccine manufacturing are key factors that lead to the demand for Vaccine packing and delivery. With the increased investment in the research and development of various new vaccines, the demand for the market will continue a forward path.
However, there are factors that hinder the market growth with the research and development focused towards needle-free distribution, which stymies the market growth as the demand for Vials, and syringes would reduce, which are the key revenue components for the Covid-19 Vaccine packaging and delivery market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystRegion-wise Analysis
Which Region is projected to Offer the Largest Opportunity for COVID-19 Vaccine Packaging and Delivery Devices Market?
In 2022, North America held the largest share of the global COVID-19 Vaccine Packaging and Delivery Devices market. The regional market is expected to be driven by fast expansion in the healthcare sector and increased awareness of the advantages of vaccination.
Rising confidence of the public in the authorized vaccines and because of public willingness to be vaccinated, the market in the Asia Pacific is expected to grow at a rapid pace during the forecast period. Moreover, the increasing patient pool along with unmet vaccine demand in untapped regions further adds to the expansion of the market. Also, the presence of developing nations like India and China is expected to further boost the market.
Country-wise Analysis
The USA COVID-19 Vaccine Packaging and Delivery Devices Market Analysis
The United States is expected to have the highest market share of US$ 776 million by the end of 2033. The growth of the Covid-19 Vaccine Packaging and Delivery Devices market in the United States can be attributed to increased Research and Development (R&D) spending to bring advances in vaccination devices. Furthermore, the existence of strong players like Johnson & Johnson, Pfizer, and Moderna will drive the market in the country.
The United Kingdom Covid-19 Vaccine Packaging and Delivery Devices Market Analysis
The market in the United Kingdom is expected to reach a valuation of US$ 94 million by 2033, growing at a CAGR of 7.3% from 2023 to 2033. The market is projected to gross an absolute dollar opportunity of US$ 48 million during the forecast period.
Japan Covid-19 Vaccine Packaging and Delivery Devices Market Analysis
In Japan, the market is expected to reach a valuation of US$ 115 million by 2033. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of US$ 66 million, growing at a CAGR of 8.9%.
South Korea Covid-19 Vaccine Packaging and Delivery Devices Market Analysis
The market in South Korea is projected to grow at a CAGR of 8.4% from 2023 to 2033. During this period, the market is projected to witness an absolute dollar opportunity of US$ 27 million and reach US$ 49 million by 2033.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Which product type will provide the largest market share for COVID-19 Vaccine Packaging and Delivery Devices providers?
Syringes commanded the largest revenue in the market, grew at a CAGR of nearly 5.4% from 2018 to 22, and are now forecasted to grow at a CAGR of 6.8% throughout the forecasted period. This is due to the advantages of using syringes over other alternatives. These are easy to use and distribute and at the same time are available at low cost. With the increased focus on research and technological advancements in syringes will significantly propel the market growth.
Competitive Analysis
Collaboration, partnership, and acquisitions are common methods used by leading players in the worldwide vaccine delivery devices market.
Some of the key players in the Covid-19 Vaccine Packaging and Delivery Devices Market include Stevanto Group, Schott AG, Gerresheimer AG, West Pharmaceutical Services Inc., Becton Dickinson and Company, SGD Pharma, Catalent Inc., B. Braun Melsungen AG, AptarGroup Inc., Cardinal Health Inc., Sealed Air Corporation, Hindustan Syringes & Medical Devices Ltd., NIPRO Corporation, PGP Glass Private Limited, Zhejiang Kangkang Medical-Devices Co Ltd, Anhui JN Medical Device Co. Ltd., and Zhejiang Jinghuan Medical Apparatus Co. Ltd.
Some of the recent developments of key COVID-19 Vaccine Packaging and Delivery Devices providers are as follows:
- In August 2022, Serum Institute of India, a vaccine manufacturer, purchased a 50% ownership in the pharma packaging business Schott Kaisha for an undisclosed sum. Schott AG is a German company that makes vials, syringes, and cartridges.
- In March 2022, Novavax and the United Kingdom Government Vaccines Taskforce agreed with GSK to assist in the manufacturing of approximately 60 million doses of the Novavax serum candidate.
- In April 2020, Pfizer announced a partnership with BioNTech which aims to advance the development of numerous COVID-19 vaccine candidates into human clinical testing using BioNTech's mRNA vaccine platforms to provide speedy global access to the vaccine if authorized. Similarly, recent developments related to the companies in COVID-19 Vaccine Packaging and Delivery Devices Market have been tracked by the team at Future Market Insights, which are available in the full report.
Market Segments Covered in COVID-19 Vaccine Packaging and Delivery Devices Market Analysis
By Product Type:
- Vials
- Plastic
- Glass
- Syringes
- Empty
- Prefilled
By Region:
- North America
- Latin America
- Europe
- APAC
- Middle East and Africa (MEA)
Frequently Asked Questions
The global market is worth more than US$ 1.1 billion at present.
The market value is projected to increase at a CAGR of around 7.1% from 2023 to 2033.
The market value increased at a CAGR of around 5.9% from 2018 to 2022.
Increased COVID-19 vaccine manufacturing and targeted drug therapies have been shaping the market.
The market for COVID-19 Vaccine Packaging and Delivery Devices Market in China is projected to expand at a CAGR of around 7.9% from 2023 to 2033.
While the market in South Korea is expected to grow at nearly 8.4%, the market in Japan is projected to register a CAGR of nearly 8.9% from 2023 to 2033.
Table of Content
1. Executive Summary | COVID-19 Vaccine Packaging and Delivery Devices Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Vials
5.3.1.1. Glass
5.3.1.2. Plastic
5.3.2. Syringes
5.3.2.1. Empty
5.3.2.2. Prefilled
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ million) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. The USA
7.2.1.2. Canada
7.2.2. By Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Type
7.4. Key Takeaways
8. Latin America Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.4. Key Takeaways
9. Europe Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. The United Kingdom
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.4. Key Takeaways
10. Asia Pacific Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.4. Key Takeaways
11. Middle East and Africa Covid-19 Vaccine Packaging and Delivery Devices Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of Middle East and Africa (MEA)
11.2.2. By Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.4. Key Takeaways
12. Key Countries Covid-19 Vaccine Packaging and Delivery Devices Market Analysis
12.1. The USA
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2022
12.1.2.1. By Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2022
12.2.2.1. By Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2022
12.3.2.1. By Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2022
12.4.2.1. By Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2022
12.5.2.1. By Type
12.6. The United Kingdom
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2022
12.6.2.1. By Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2022
12.7.2.1. By Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2022
12.8.2.1. By Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2022
12.9.2.1. By Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2022
12.10.2.1. By Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2022
12.11.2.1. By Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2022
12.12.2.1. By Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2022
12.13.2.1. By Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2022
12.14.2.1. By Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2022
12.15.2.1. By Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2022
12.16.2.1. By Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2022
12.17.2.1. By Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2022
12.18.2.1. By Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2022
12.19.2.1. By Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Stevanto Group
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. Gerresheimer AG
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. West Pharmaceutical Services Inc.
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Becton Dickinson and Company
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. SGD Pharma
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Catalent Inc.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. B. Braun Melsungen AG
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. AptarGroup Inc.
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Cardinal Health Inc.
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Sealed Air Corporation
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
14.1.11. Hindustan Syringes & Medical Devices Ltd.
14.1.11.1. Overview
14.1.11.2. Product Portfolio
14.1.11.3. Profitability by Market Segments
14.1.11.4. Sales Footprint
14.1.11.5. Strategy Overview
14.1.11.5.1. Marketing Strategy
14.1.12. NIPRO Corporation
14.1.12.1. Overview
14.1.12.2. Product Portfolio
14.1.12.3. Profitability by Market Segments
14.1.12.4. Sales Footprint
14.1.12.5. Strategy Overview
14.1.12.5.1. Marketing Strategy
14.1.13. PGP Glass Private Limited
14.1.13.1. Overview
14.1.13.2. Product Portfolio
14.1.13.3. Profitability by Market Segments
14.1.13.4. Sales Footprint
14.1.13.5. Strategy Overview
14.1.13.5.1. Marketing Strategy
14.1.14. Zhejiang Kangkang Medical-Devices Co Ltd
14.1.14.1. Overview
14.1.14.2. Product Portfolio
14.1.14.3. Profitability by Market Segments
14.1.14.4. Sales Footprint
14.1.14.5. Strategy Overview
14.1.14.5.1. Marketing Strategy
14.1.15. Anhui JN Medical Device Co. Ltd.
14.1.15.1. Overview
14.1.15.2. Product Portfolio
14.1.15.3. Profitability by Market Segments
14.1.15.4. Sales Footprint
14.1.15.5. Strategy Overview
14.1.15.5.1. Marketing Strategy
14.1.16. Zhejiang Jinghuan Medical Apparatus Co. Ltd.
14.1.16.1. Overview
14.1.16.2. Product Portfolio
14.1.16.3. Profitability by Market Segments
14.1.16.4. Sales Footprint
14.1.16.5. Strategy Overview
14.1.16.5.1. Marketing Strategy
14.1.17. Schott AG
14.1.17.1. Overview
14.1.17.2. Product Portfolio
14.1.17.3. Profitability by Market Segments
14.1.17.4. Sales Footprint
14.1.17.5. Strategy Overview
14.1.17.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ million) Forecast by Type, 2018 to 2033
Table 3: North America Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 4: North America Market Value (US$ million) Forecast by Type, 2018 to 2033
Table 5: Latin America Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 6: Latin America Market Value (US$ million) Forecast by Type, 2018 to 2033
Table 7: Europe Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 8: Europe Market Value (US$ million) Forecast by Type, 2018 to 2033
Table 9: Asia Pacific Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 10: Asia Pacific Market Value (US$ million) Forecast by Type, 2018 to 2033
Table 11: Middle East and Africa Market Value (US$ million) Forecast by Country, 2018 to 2033
Table 12: Middle East and Africa Market Value (US$ million) Forecast by Type, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ million) by Type, 2023 to 2033
Figure 2: Global Market Value (US$ million) by Region, 2023 to 2033
Figure 3: Global Market Value (US$ million) Analysis by Region, 2018 to 2033
Figure 4: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 5: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 6: Global Market Value (US$ million) Analysis by Type, 2018 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 9: Global Market Attractiveness by Type, 2023 to 2033
Figure 10: Global Market Attractiveness by Region, 2023 to 2033
Figure 11: North America Market Value (US$ million) by Type, 2023 to 2033
Figure 12: North America Market Value (US$ million) by Country, 2023 to 2033
Figure 13: North America Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 14: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 15: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 16: North America Market Value (US$ million) Analysis by Type, 2018 to 2033
Figure 17: North America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 18: North America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 19: North America Market Attractiveness by Type, 2023 to 2033
Figure 20: North America Market Attractiveness by Country, 2023 to 2033
Figure 21: Latin America Market Value (US$ million) by Type, 2023 to 2033
Figure 22: Latin America Market Value (US$ million) by Country, 2023 to 2033
Figure 23: Latin America Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 24: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 25: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 26: Latin America Market Value (US$ million) Analysis by Type, 2018 to 2033
Figure 27: Latin America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 28: Latin America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 29: Latin America Market Attractiveness by Type, 2023 to 2033
Figure 30: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 31: Europe Market Value (US$ million) by Type, 2023 to 2033
Figure 32: Europe Market Value (US$ million) by Country, 2023 to 2033
Figure 33: Europe Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 34: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 35: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 36: Europe Market Value (US$ million) Analysis by Type, 2018 to 2033
Figure 37: Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 38: Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 39: Europe Market Attractiveness by Type, 2023 to 2033
Figure 40: Europe Market Attractiveness by Country, 2023 to 2033
Figure 41: Asia Pacific Market Value (US$ million) by Type, 2023 to 2033
Figure 42: Asia Pacific Market Value (US$ million) by Country, 2023 to 2033
Figure 43: Asia Pacific Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 44: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 45: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 46: Asia Pacific Market Value (US$ million) Analysis by Type, 2018 to 2033
Figure 47: Asia Pacific Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 48: Asia Pacific Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 49: Asia Pacific Market Attractiveness by Type, 2023 to 2033
Figure 50: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 51: Middle East and Africa Market Value (US$ million) by Type, 2023 to 2033
Figure 52: Middle East and Africa Market Value (US$ million) by Country, 2023 to 2033
Figure 53: Middle East and Africa Market Value (US$ million) Analysis by Country, 2018 to 2033
Figure 54: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 55: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 56: Middle East and Africa Market Value (US$ million) Analysis by Type, 2018 to 2033
Figure 57: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 58: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 59: Middle East and Africa Market Attractiveness by Type, 2023 to 2033
Figure 60: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
